Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD3882 |
Suspended |
0.8563 |
High Similarity |
NPD2801 |
Approved |
0.848 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8343 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8324 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8314 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8286 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8284 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8253 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8192 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8136 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8125 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8068 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7977 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7956 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD919 |
Approved |
0.7912 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD3749 |
Approved |
0.787 |
Intermediate Similarity |
NPD2533 |
Approved |
0.787 |
Intermediate Similarity |
NPD2532 |
Approved |
0.787 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7849 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7816 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7747 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7746 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7705 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7054 |
Approved |
0.767 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7663 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7609 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6799 |
Approved |
0.76 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7579 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7571 |
Intermediate Similarity |
NPD5402 |
Approved |
0.756 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.756 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7545 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7542 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7527 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD943 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6100 |
Approved |
0.75 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD920 |
Approved |
0.7456 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7446 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7396 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7396 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7377 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD37 |
Approved |
0.7356 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7322 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7322 |
Intermediate Similarity |
NPD5710 |
Approved |
0.731 |
Intermediate Similarity |
NPD6776 |
Approved |
0.731 |
Intermediate Similarity |
NPD6779 |
Approved |
0.731 |
Intermediate Similarity |
NPD6780 |
Approved |
0.731 |
Intermediate Similarity |
NPD6781 |
Approved |
0.731 |
Intermediate Similarity |
NPD6778 |
Approved |
0.731 |
Intermediate Similarity |
NPD6782 |
Approved |
0.731 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7295 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7277 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7241 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7228 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD447 |
Suspended |
0.716 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.712 |
Intermediate Similarity |
NPD8312 |
Approved |
0.712 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7074 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7056 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7043 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1613 |
Approved |
0.6994 |
Remote Similarity |
NPD5404 |
Approved |
0.6994 |
Remote Similarity |
NPD5406 |
Approved |
0.6994 |
Remote Similarity |
NPD5405 |
Approved |
0.6994 |
Remote Similarity |
NPD5408 |
Approved |
0.699 |
Remote Similarity |
NPD7874 |
Approved |
0.699 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6190 |
Approved |
0.6984 |
Remote Similarity |
NPD2163 |
Approved |
0.6982 |
Remote Similarity |
NPD2313 |
Discontinued |
0.698 |
Remote Similarity |
NPD3057 |
Approved |
0.698 |
Remote Similarity |
NPD2491 |
Approved |
0.6966 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6957 |
Remote Similarity |
NPD7801 |
Approved |
0.6957 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.695 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.695 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD7003 |
Approved |
0.6931 |
Remote Similarity |
NPD3450 |
Approved |
0.6931 |
Remote Similarity |
NPD3452 |
Approved |
0.6928 |
Remote Similarity |
NPD6696 |
Suspended |
0.6927 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6916 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD4582 |
Approved |
0.6912 |
Remote Similarity |
NPD4583 |
Approved |
0.6906 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6906 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD2296 |
Approved |
0.6897 |
Remote Similarity |
NPD3533 |
Approved |
0.6897 |
Remote Similarity |
NPD3448 |
Approved |
0.6897 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD2972 |
Approved |
0.6886 |
Remote Similarity |
NPD1470 |
Approved |
0.6863 |
Remote Similarity |
NPD4004 |
Approved |
0.6863 |
Remote Similarity |
NPD4002 |
Approved |
0.6857 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6856 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD1653 |
Approved |
0.6839 |
Remote Similarity |
NPD6764 |
Approved |
0.6839 |
Remote Similarity |
NPD6765 |
Approved |
0.6839 |
Remote Similarity |
NPD7240 |
Approved |
0.6821 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD2488 |
Approved |
0.6818 |
Remote Similarity |
NPD2490 |
Approved |
0.6816 |
Remote Similarity |
NPD2975 |
Approved |
0.6816 |
Remote Similarity |
NPD2973 |
Approved |
0.6816 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD2974 |
Approved |
0.6809 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6805 |
Remote Similarity |
NPD9494 |
Approved |
0.6802
|
Remote Similarity |
NPD4060 |
Phase 1 |